Back to ROIV
BAKER BROS. ADVISORS LP → ROIV
BAKER BROS. ADVISORS LP ROIV Position History
Roivant Sciences Ltd. • Healthcare
Quarters held
4
Latest value
$133.9M
Q3 2026
Peak value
$166.9M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $120.5M |
| Q1 2026 | $134.8M |
| Q2 2026 | $166.9M |
| Q3 2026 | $133.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $133.9M | 3.66M | — | — |
| Q2 2026 | $166.9M | 4.72M | — | — |
| Q1 2026 | $134.8M | 4.87M | — | — |
| Q4 2025 | $120.5M | 5.56M | — | — |
Other funds holding ROIV
$1.9B
$1.7B
$1.3B
$1.3B
$1.2B
$1.2B
$1.2B
$1.1B